Multiple Sclerosis Society continues to fund Vitamin D research

National MS Society Awards $12M to 40 Research Projects in US and Elsewhere

"A team led by Anne-Louise Ponsonby at the Australian National University was also given support. These researchers will examine how the environment — including exposure to sunlight, vitamin D, and infections — might impact genes and possibly trigger disease onset."

📄 Download the PDF from VitaminDWiki

Clipped from PDF

Anne-Louise Ponsonby, PhD, The Australian National University. Canberra, Australia

Award: Research Grant Term: 10/1/18-9/30/21 Funding: $555,546

Title: Identifying epigenetic factors involved in MS onset: utilizing population-based studies with genetic and environmental measures. Summary: Researchers at the Australian National University are studying a link between the environment and how genes are turned on and off to trigger the onset of MS.

Background: The cause of MS is complex and not fully understood, but is thought to involve the interaction between an individual’s genes and environmental factors, such as exposure to sunlight, vitamin D or infections. This research will take advantage of a large population study (the Australian-based Ausimmune Study) that was established to track MS triggering factors.

• Overview MS and vitamin D

• Vitamin D is the only dietary supplement which significantly benefits MS – JAMA April 2018

• Multiple sclerosis helped some by 10,000 IU of vitamin D daily avg. for 3 months – RCT Sept 2016

• Vitamin D has already cleared 100 percent of lesions from over 1,000 MS patients in Brazil

• Vitamin D is the real Multiple Sclerosis Therapy, not an alternative therapy – Coimbra July 2018

• Multiple Sclerosis relapse rate reduced by half if add some vitamin D – July 2017

• Multiple Sclerosis, Alzheimer’s and Parkinson’s need more than 30 ng of Vitamin D – review Nov 2017